Elevated circulating resistin levels observed in obesity and type 2 diabetes mellitus contribute to insulin resistance through inhibition of adenosine monophosphate kinase (AMPK) activity in hepatic and skeletal muscle tissues, thereby disrupting insulin signaling pathways (5). This evidence concerns the gene RETN and diabetes mellitus.